Yasuharu Nishimura

7.5k total citations
171 papers, 6.0k citations indexed

About

Yasuharu Nishimura is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yasuharu Nishimura has authored 171 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Immunology, 57 papers in Molecular Biology and 50 papers in Oncology. Recurrent topics in Yasuharu Nishimura's work include Immunotherapy and Immune Responses (74 papers), Immune Cell Function and Interaction (54 papers) and T-cell and B-cell Immunology (54 papers). Yasuharu Nishimura is often cited by papers focused on Immunotherapy and Immune Responses (74 papers), Immune Cell Function and Interaction (54 papers) and T-cell and B-cell Immunology (54 papers). Yasuharu Nishimura collaborates with scholars based in Japan, United States and Germany. Yasuharu Nishimura's co-authors include Satoru Senju, Tetsuya Nakatsura, Hirotake Tsukamoto, Shinya Hirata, Sho Matsushita, Takehiko Sasazuki, Tokunori Ikeda, Yoshihiro Yoshitake, Atsushi Irie and Daiki Fukuma and has published in prestigious journals such as Nature, Science and JAMA.

In The Last Decade

Yasuharu Nishimura

170 papers receiving 5.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yasuharu Nishimura Japan	44	3.0k	2.6k	1.8k	526	480	171	6.0k
Satoru Senju Japan	38	2.7k 0.9×	3.1k 1.2×	1.8k 1.0×	348 0.7×	326 0.7×	101	5.8k
Rie Watanabe‐Fukunaga Japan	19	3.2k 1.1×	4.2k 1.6×	976 0.5×	801 1.5×	345 0.7×	21	6.9k
Akio Matsuzawa Japan	25	3.7k 1.2×	2.4k 0.9×	1.6k 0.9×	632 1.2×	262 0.5×	146	6.2k
Darren P. Baker United States	40	1.8k 0.6×	3.3k 1.3×	1.4k 0.8×	617 1.2×	253 0.5×	103	5.8k
Amnon Peled Israel	49	4.7k 1.6×	2.9k 1.1×	4.7k 2.6×	469 0.9×	319 0.7×	138	10.3k
Stephen G. Emerson United States	46	4.0k 1.3×	2.1k 0.8×	1.7k 1.0×	316 0.6×	316 0.7×	117	8.2k
Joost J. van den Oord Belgium	48	1.8k 0.6×	2.8k 1.1×	1.9k 1.1×	1.1k 2.0×	565 1.2×	167	7.8k
Naoto Itoh Japan	26	3.5k 1.2×	4.2k 1.6×	1.1k 0.6×	938 1.8×	326 0.7×	50	7.9k
Christine Ambrose United States	29	4.1k 1.4×	2.4k 0.9×	834 0.5×	329 0.6×	962 2.0×	52	7.1k
Thomas Wirth Germany	44	2.1k 0.7×	2.5k 1.0×	1.6k 0.9×	702 1.3×	283 0.6×	178	6.3k

Countries citing papers authored by Yasuharu Nishimura

Since Specialization

Citations

This map shows the geographic impact of Yasuharu Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuharu Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuharu Nishimura more than expected).

Fields of papers citing papers by Yasuharu Nishimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuharu Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuharu Nishimura. The network helps show where Yasuharu Nishimura may publish in the future.

Co-authorship network of co-authors of Yasuharu Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuharu Nishimura. A scholar is included among the top collaborators of Yasuharu Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuharu Nishimura. Yasuharu Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsukamoto, Hirotake, Koji Fujieda, Azusa Miyashita, et al.. (2018). Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment. Cancer Research. 78(17). 5011–5022. 234 indexed citations

Tsukamoto, Hirotake, Koji Fujieda, Masatoshi Hirayama, et al.. (2017). Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. Cancer Research. 77(9). 2279–2291. 46 indexed citations

Miyashita, Azusa, Satoshi Fukushima, Satoshi Nakahara, et al.. (2016). Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons. Cancer Immunology Research. 4(3). 248–258. 24 indexed citations

Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS. Clinical Cancer Research. 21(2). 312–321. 123 indexed citations

Haruta, Miwa, Keiko Matsumura, Koutaro Takamatsu, et al.. (2014). Therapy of Peritoneally Disseminated Colon Cancer by TAP-Deficient Embryonic Stem Cell–Derived Macrophages in Allogeneic Recipients. The Journal of Immunology. 193(4). 2024–2033. 11 indexed citations

Ishimura, Ryuta, Gábor Nagy, Iván Dotú, et al.. (2014). Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science. 345(6195). 455–459. 328 indexed citations

Senju, Satoru, Miwa Haruta, Yusuke Matsunaga, et al.. (2014). Application of iPS cell-derived macrophages to cancer therapy. OncoImmunology. 3(3). e27927–e27927. 12 indexed citations

Ikeda, Tokunori, Shinya Hirata, Koutaro Takamatsu, et al.. (2014). Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells. PLoS ONE. 9(12). e115198–e115198. 11 indexed citations

Tsukamoto, Hirotake, et al.. (2013). Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression. Cancer Immunology Research. 1(1). 64–76. 69 indexed citations

10.

Tomita, Yusuke, Akira Yuno, Hirotake Tsukamoto, et al.. (2013). Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor. Clinical Cancer Research. 19(16). 4508–4520. 50 indexed citations

11.

Irie, Atsushi, Yoji Murakami, Magdalena Nowak, et al.. (2010). Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology. 157(3). 786–792. 61 indexed citations

12.

Imai, Katsunori, Shinya Hirata, Atsushi Irie, et al.. (2008). Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers. Clinical Cancer Research. 14(20). 6487–6495. 90 indexed citations

13.

Motomura, Yutaka, Yoshiaki Ikuta, Hiroyuki Komori, et al.. (2008). HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: Preclinical study using mice. International Journal of Oncology. 32(5). 985–90. 39 indexed citations

14.

Hirata, Shinya, Hidetake Matsuyoshi, Daiki Fukuma, et al.. (2007). Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL. The Journal of Immunology. 178(2). 918–925. 42 indexed citations

15.

Hirata, Shinya, Satoru Senju, Hidetake Matsuyoshi, et al.. (2005). Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand. The Journal of Immunology. 174(4). 1888–1897. 109 indexed citations

16.

Matsuyoshi, Hidetake, Satoru Senju, Shinya Hirata, et al.. (2004). Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination. The Journal of Immunology. 172(2). 776–786. 55 indexed citations

17.

Zeki, Kazuya, Yoshiya Tanaka, Isao Morimoto, et al.. (1998). Induction of expression of MHC‐class‐II antigen on human thyroid carcinoma by wild‐type p53. International Journal of Cancer. 75(3). 391–395. 3 indexed citations

18.

Zeki, Kazuya, Yoshiya Tanaka, Isao Morimoto, et al.. (1998). Induction of expression of MHC-class-II antigen on human thyroid carcinoma by wild-type p53. International Journal of Cancer. 75(3). 391–395. 12 indexed citations

19.

Miwa, Kiyoshi, et al.. (1992). Production of Monoclonal Antibodies Specific to Major Allergens of Cryptomeria japonica Pollen. Hybridoma. 11(3). 361–366. 2 indexed citations

20.

Nishimura, Yasuharu, Seiichiro Minato, Yasuto Itoyama, et al.. (1991). A possible association between HLA and HTLV‐I‐associated myelopathy (HAM) in Japanese. Tissue Antigens. 37(5). 230–231. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact